STRO · Sutro Biopharma, Inc.
$25.28
+1.13 (+4.68%)
At close · Aug 7
Market Cap
$400.18M
Shares
16.57M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-01-20 | BARBARA LEYMAN | Former Officer | 8,929 | 2026-01-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-01-29 | NICKI J VASQUEZ | Officer | 12,185 | 2024-01-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-08-25 | Shtylla Brunilda | Officer | 27,041 | 2023-08-25 | ETRADE FINANCIAL CORPORATION |
Showing 1–3 of 3 filings
Key facts
CIK
1382101
CUSIP
869367201
13F (30d)
18 filings
18 filers
Visit website
Investor relations